121
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Coincidence of Candida Endophthalmitis, and Aspergillus and Pneumocystis jirovecii Pneumonia in a COVID-19 Patient: Case Report

, MD, , MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 1291-1294 | Received 16 May 2022, Accepted 02 Mar 2023, Published online: 23 Mar 2023

References

  • Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: a global health emergency. Sci Total Environ. 2020;730:138996. doi:10.1016/j.scitotenv.2020.138996.
  • World Health Organization. WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int/. Updated November 17, 2022.
  • Bartleson JM, Radenkovic D, Covarrubias AJ, Furman D, Winer DA, Verdin E. SARS-CoV-2, COVID-19 and the ageing immune system. Nat Aging. 2021;1(9):769–782. doi:10.1038/s43587-021-00114-7.
  • Değirmenci MFK, Yalçındağ FN, Tugal-Tutkun İ. COVID-19 and the use of immunomodulatory agents in ophthalmology. Turk J Ophthalmol. 2021;51(4):231–242. doi:10.4274/tjo.galenos.2021.68252.
  • Pemán J, Ruiz-Gaitán A, García-Vidal C, et al. Fungal co-infection in COVID-19 patients: should we be concerned? Rev Iberoam Micología. 2020;37(2):41–46. doi:10.1016/j.riam.2020.07.001.
  • Iqbal A, Ramzan M, Akhtar A, Ahtesham A, Aslam S, Khalid J. COVID-associated pulmonary aspergillosis and its related outcomes: a single-center prospective observational study. Cureus. 2021;13(8):e16982. doi:10.7759/cureus.16982.
  • Arastehfar A, Carvalho A, Nguyen MH, et al. COVID-19-Associated Candidiasis (CAC): an underestimated complication in the absence of immunological predispositions? J Fungi (Basel). 2020;6(4):211. doi:10.3390/jof6040211.
  • Bretagne S, Sitbon K, Botterel F, et al. COVID-19-associated pulmonary aspergillosis, fungemia, and pneumocystosis in the intensive care unit: a retrospective multicenter observational cohort during the first French pandemic wave. Microbiol Spectr. 2021;9(2):e0113821. doi:10.1128/Spectrum.01138-21.
  • Garbee DD, Pierce SS, Manning J. Opportunistic fungal infections in critical care units. Crit Care Nurs Clin North Am. 2017;29(1):67–79. doi:10.1016/j.cnc.2016.09.011.
  • Seidelman J, Fleece M, Bloom A, et al. Endogenous Candida endophthalmitis: who is really at risk? J Infect. 2021;82(2):276–281. doi:10.1016/j.jinf.2020.12.032.
  • Roudbary M, Kumar S, Kumar A, Černáková L, Nikoomanesh F, Rodrigues CF. Overview on the prevalence of fungal infections, immune response, and microbiome role in COVID-19 patients. J Fungi (Basel). 2021;7(9):720. doi:10.3390/jof7090720.
  • Bhatt K, Agolli A, Patel MH, et al. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries (Craiova, Romania). 2021;9(1):e126. doi:10.15190/d.2021.5.
  • Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-0.
  • Coşkun AS, Durmaz Ş. Fungal infections in COVID-19 intensive care patients. Pol J Microbiol. 2021;70(3):395–400. doi:10.33073/pjm-2021-039.
  • Ljubin-Sternak S, Meštrović T, Lukšić I, Mijač M, Vraneš J. Seasonal coronaviruses and other neglected respiratory viruses: a global perspective and a local snapshot. Front Public Health. 2021;9:691163. doi:10.3389/fpubh.2021.691163.
  • Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021;113:115–129. doi:10.1016/j.jhin.2021.04.012.
  • Chhajed PN, Nene A, Abhyankar N, et al. Conventional flexible bronchoscopy during the COVID pandemic: a consensus statement from the Indian Association for Bronchology. Lung India. 2021;38(7):S105–s15. doi:10.4103/lungindia.lungindia_953_20.
  • Gago S, Denning DW, Bowyer P. Pathophysiological aspects of Aspergillus colonization in disease. Med Mycol. 2019;57(Supplement_2):S219–s27. doi:10.1093/mmy/myy076.
  • Jenks JD, Hoenigl M. Treatment of aspergillosis. J Fungi (Basel). 2018;4(3):98. doi:10.3390/jof4030098.
  • Szydłowicz M, Matos O. Pneumocystis pneumonia in the COVID-19 pandemic era: similarities and challenges. Trends Parasitol. 2021;37(10):859–862. doi:10.1016/j.pt.2021.07.010.
  • Misch EA, Safdar N. Updated guidelines for the diagnosis and management of aspergillosis. J Thorac Dis. 2016;8(12):E1771–e6. doi:10.21037/jtd.2016.12.76.
  • Mantadakis E. Pneumocystis jirovecii pneumonia in children with hematological malignancies: diagnosis and approaches to management. J Fungi (Basel). 2020;6(4):331. doi:10.3390/jof6040331.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.